Clinical efficacy of a new antiinflammatory drug with free radicals scavenging properties: superoxide dismutase (SOD) and catalase of human origin.
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy; D001855:Bone Marrow Diseases / Q000188:drug therapy; D002374:Catalase / Q000378:metabolism / Q000627:therapeutic use*; D002648:Child; D003093:Colitis, Ulcerative / Q000188:drug therapy; D004338:Drug Combinations / Q000378:metabolism / Q000627:therapeutic use; D004341:Drug Evaluation; D005609:Free Radicals; D006801:Humans; D002534:Hypoxia, Brain / Q000188:drug therapy; D010101:Oxygen Consumption / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy; D012772:Shock, Septic / Q000188:drug therapy; D013482:Superoxide Dismutase / Q000378:metabolism / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D005609:Free Radicals; D002374:Catalase; D013482:Superoxide Dismutase; C050165:epurox